Concepedia

Author

James G. Kahn

University of California, San FranciscoORCID

Also Known As

Bennett, Rod, Bukusi, Elizabeth A., Cole, Stephen R., Garg, Navneet, J G Kahn, J Kahn, J. G. Kahn, J. Kahn, J.G. Kahn, James G Kahn

295

Publications

9.6K

Citations

50

H-Index

155

Concepts

All Affiliations

University of California, San FranciscoLee UniversityGlobal Brain Health InstituteSan Francisco AIDS FoundationKenya Medical Research Institute
JG

About

James G. Kahn is an author at University of California, San Francisco specializing in medicine, public health, and health economics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

15

21

1.2K

2

Public Health

15

20

957

3

Management

2

2

160

4

Education

1

1

39

5

Health Sciences

1

1

32

James G. Kahn

×

129

Publications

7.5K

Citations

45

H-Index

YearCitations

Thresholds for the cost–effectiveness of interventions: alternative approaches

Elliot Marseille, Bruce A. Larson, Dhruv S. Kazi,

Bulletin of the World Health Organization

2014

846

‘Mobile’ Health Needs And Opportunities In Developing Countries

James G. Kahn, Joshua Yang, James S. Kahn

Health Affairs

2010

410

Gestational diabetes mellitus: results from a survey of country prevalence and practices

Aliya Jiwani, Elliot Marseille, Nicolai Lohse,

The Journal of Maternal-Fetal & Neonatal Medicine

2011

315

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

Elliot Marseille, James G. Kahn, Francis Mmiro,

The Lancet

1999

264

Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use

Katherine L. Possin, Jennifer Merrilees, Sarah Dulaney,

JAMA Internal Medicine

2019

255

Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting

James G. Kahn, Elliot Marseille, Bertran Auvert

PLoS Medicine

2006

235

Reassessing HIV Prevention

Malcolm Potts, Daniel T. Halperin, Douglas Kirby,

Science

2008

219

A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab

Fernando Velayos, James G. Kahn, William J. Sandborn,

Clinical Gastroenterology and Hepatology

2013

176

Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050

Reuben Granich, James G. Kahn, Rod Bennett,

PLoS ONE

2012

174

Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial

Gideon Amanyire, Fred C. Semitala, Jennifer Namusobya,

The Lancet HIV

2016

142

Page 1